Korea Sees China FTA Impacting Mainly Substance Imports
This article was originally published in PharmAsia News
Executive Summary
With South Korea set to sign an official free trade agreement with China as early as May after a tentative deal in February, the government and industries have been quickening efforts to gauge the implications for South Korea's economy. Although the impact on the pharma sector may be limited to drug substances in the near term, the government and industry are looking to capitalize on opportunities in the massive Chinese market.